Sabra Dipping Company Issues Voluntary Recall Of Certain Hummus Products Because Of Possible Health Risks

Sabra Dipping Co., LLC is voluntarily recalling certain hummus products made prior to November 8, 2016 due to concerns over Listeria monocytogenes, which was identified at the manufacturing facility but not in tested finished product. The recall includes the products listed below; these were distributed to retail outlets, including food service accounts and supermarkets, in the U.S. and Canada.

H-E-B Issues Precautionary Baby Food Recall

San Antonio, TX – H-E-B announced today that it has issued a precautionary recall of its entire H-E-B Baby Food 2 pack 4 oz. cups product line only. As of this afternoon, the H-E-B Baby Food 2 pack 4 oz. cups were removed from shelves out of an abundance of caution due to a customer report of a small piece of rubber found inside a single container of one variety of the product.

Nutra Manufacturing, Inc. Announces Nationwide Voluntary Recall of One Lot of GNC Women’s Ultra Mega Time Release 180 count Dietary Supplement

Pittsburgh, PA, Nutra Manufacturing, Inc. (“Nutra”) today announced that it is initiating a nationwide, voluntary recall of one lot of GNC Women’s Ultra Mega Time Release dietary supplement product sold in 180 count containers UPC 048107158910, lot number 3044FQ2024, with an expiration date of June 2018 due to the fact the product may contain an undeclared major food allergen, milk.

Nutra Manufacturing, Inc. Announces Nationwide Voluntary Recall of One Lot of GNC Women’s Ultra Mega Time Release 180 count Dietary Supplement

Pittsburgh, PA, Nutra Manufacturing, Inc. (“Nutra”) today announced that it is initiating a nationwide, voluntary recall of one lot of GNC Women’s Ultra Mega Time Release dietary supplement product sold in 180 count containers UPC 048107158910, lot number 3044FQ2024, with an expiration date of June 2018 due to the fact the product may contain an undeclared major food allergen, milk.

FDA research to help speed development of Zika virus vaccines and therapeutics

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.